OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The possible place for psychedelics in pharmacotherapy of mental disorders
Adam Wojtas
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1313-1325
Open Access | Times Cited: 6
Adam Wojtas
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1313-1325
Open Access | Times Cited: 6
Showing 6 citing articles:
Exploring psilocybin’s role in mental health and palliative medicine: a path to improved well-being
Maria-Alejandra Umbacia, Marta León, Jose-Manuel Quintero, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Maria-Alejandra Umbacia, Marta León, Jose-Manuel Quintero, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics
Sara Castanheira, Catarina Gomes, Joana Bicker, et al.
Drug Discovery Today (2025), pp. 104371-104371
Open Access
Sara Castanheira, Catarina Gomes, Joana Bicker, et al.
Drug Discovery Today (2025), pp. 104371-104371
Open Access
Psychedelic therapy – refining the claim of a paradigm shift
Helena D. Aicher, Max Wolff, Uwe Herwig
International Review of Psychiatry (2024), pp. 1-8
Open Access | Times Cited: 3
Helena D. Aicher, Max Wolff, Uwe Herwig
International Review of Psychiatry (2024), pp. 1-8
Open Access | Times Cited: 3
Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
Wirginia Krzyściak, Beata Bystrowska, Paulina Karcz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2294-2294
Open Access | Times Cited: 2
Wirginia Krzyściak, Beata Bystrowska, Paulina Karcz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2294-2294
Open Access | Times Cited: 2
Psilocybin in pharmacotherapy of obsessive-compulsive disorder
Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 911-925
Open Access | Times Cited: 2
Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 911-925
Open Access | Times Cited: 2
Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023)
Closed Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023)
Closed Access
